Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|June 10, 2015
MEK inhibitors beyond monotherapy: current and future developmentIan E Templeton, Luna Musib
The AAPS Journal|February 15, 2018
Pediatric Dose Selection and Utility of PBPK in Determining DoseIan E Templeton, Nicholas S Jones, Luna Musib
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 21, 2011
Predictive utility of in vitro rifampin induction data generated in fresh and cryopreserved human hepatocytes, Fa2N-4, and HepaRG cellsIan E Templeton, J Brian Houston, Aleksandra Galetin
The AAPS Journal|June 21, 2023
Evaluation of the Potential for Drug-Drug Interactions with Inhaled Itraconazole Using Physiologically Based Pharmacokinetic Modelling, Based on Phase 1 Clinical DataMackenzie Bergagnini-Kolev, Katie Kane, Ian E Templeton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 30, 2025
Real-world application of physiologically based pharmacokinetic models in drug discoveryLaura G A Santos, Swati Jaiswal, Kuan-Fu Chen, et al.
Phytotherapy Research : PTR|October 13, 2005
Pharmacokinetics of valerenic acid after administration of valerian in healthy subjectsGail D Anderson, Gary W Elmer, Eric D Kantor, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 20, 2023
Real-world application of PBPK in drug discoveryLaura G A Santos, Swati Jaiswal, Kuan-Fu Chen, et al.
Clinical Pharmacology and Therapeutics|July 19, 2023
Physiologically Based Pharmacokinetic Modeling and Simulation of Mavacamten Exposure with Drug-Drug Interactions from CYP Inducers and Inhibitors by CYP2C19 PhenotypeManting Chiang, Caroline Sychterz, Vidya Perera, et al.
Pharmaceutics|May 27, 2023
Physiologically Based Pharmacokinetic Model Development and Verification for Bioequivalence Testing of Bempedoic Acid Oral Suspension and Reference Tablet FormulationBenny M Amore, Nikunjkumar Patel, Priya Batheja, et al.
Clinical Pharmacology in Drug Development|March 27, 2025
Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions of Soticlestat as a Victim of CYP Induction and Inhibition, and as a Perpetrator of CYP and P-Glycoprotein InhibitionHongxia Jia, T Eric Ballard, Liming Zhang, et al.
Pageof 2